U.S. Markets closed

G1 Therapeutics, Inc. (G1H.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
5.97-0.14 (-2.29%)
At close: 08:00AM CET
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in EUR

Valuation Measures4

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.90
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 316.91
52 Week Low 33.79
50-Day Moving Average 35.59
200-Day Moving Average 38.00

Share Statistics

Avg Vol (3 month) 3260
Avg Vol (10 day) 3N/A
Shares Outstanding 542.52M
Implied Shares Outstanding 6N/A
Float 835.94M
% Held by Insiders 19.09%
% Held by Institutions 154.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-577.60%

Management Effectiveness

Return on Assets (ttm)-43.80%
Return on Equity (ttm)-122.44%

Income Statement

Revenue (ttm)28.13M
Revenue Per Share (ttm)0.66
Quarterly Revenue Growth (yoy)60.10%
Gross Profit (ttm)29.46M
EBITDA -161.99M
Net Income Avi to Common (ttm)-171.13M
Diluted EPS (ttm)-2.18
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.96M
Total Cash Per Share (mrq)3.37
Total Debt (mrq)82.3M
Total Debt/Equity (mrq)124.09
Current Ratio (mrq)4.75
Book Value Per Share (mrq)4.65

Cash Flow Statement

Operating Cash Flow (ttm)-145.48M
Levered Free Cash Flow (ttm)-82.35M